Session: 63. HIV Clinical Care and Outcomes
Thursday, October 5, 2017: 12:30 PM Background. The use of combination antiretroviral therapy (ARVT) has made it possible to halt HIV replication, achieve CD4+ recovery and immune reconstitution. Some patients with long-term viral suppression never adequately recover their CD4+ count and manifest increased mortality. Age, CD4+ nadir, Hepatitis C infection have been associated with incomplete immune recovery. By matching for age, gender, and CD4 nadir, we aim to elucidate the role of clinical factors in virally suppressed patients with suboptimal CD4 recovery.
Methods. Retrospective record review of patients with CD4 <200 (Cases) and CD4 >500 (Controls) with over 2 years of viral supression (viral load <200) on ARVT for the same duration, was conducted. One case was matched to 2 controls by age, gender and CD4 nadir. Associations between variables were assessed using univariable exact conditional logistic regressions.
Results. Of the 1265 charts reviewed, 13 cases were identified. A unit higher BMI was significantly associated with a 13% lower odds of having low CD4 (P = 0.04). Higher hemoglobin A1c (A1c) was associated with 82% lower odds of having low CD4 (P = 0.02). Other non-significant comparisons include ethnicity; 33% cases were Hispanic vs. 16% controls. Gastrointestinal (GI) symptoms were more common in the cases (83% vs. 50%), as was lymphadenopathy (LAD) (36.4% vs. 25%). Mean years since diagnosis was longer in cases (19.2 vs. 16.7) despite the duration of ARVT being longer in controls. Mean number of comorbidities was higher in cases (3.17 vs. 2.75). Controls had more statin use (45.8% vs. 25%).
Conclusion. Incomplete CD4 recovery was significantly associated with lower BMI, suggesting that despite viral suppression, these patients are vulnerable to metabolic issues that affect uncontrolled HIV patients. We hypothesize that rapid control of HIV in this suburban population was associated with weight gain and note that the BMI in controls was in the obesity range. Statin use may play a protective role in the controls, perhaps due to its anti-inflammatory properties. Trends in GI symptoms, LAD, number of comorbidities, albeit not statistically significant, seem to be important. Due to small sample size, this study was underpowered to fully assess the effect of these factors. Thus this study should be considered exploratory.
Disclosures. Background. Chronic pain in HIV infected patients is common in the ambulatory setting, the majority of which is musculoskeletal (MSK). Addressing patient's pain is essential but physicians often fail to adequately manage MSK pain. Additionally, HIV patients with chronic non-cancer pain (CNCP) have a 2-fold increase in the risk of opioid misuse compared with the general population. We sought to determine the extent of pain complaints and opioid prescriptions in our HIV clinic as well as assess the comfort and ability of our residents to develop a comprehensive pain management plan.
Methods. We performed a chart review of all patients seen by our Internal Medicine (IM) residents in the HIV primary care in Detroit, MI from 01/2017-05/2017 and collected demographic and pain-related data. We also surveyed IM residents assigned to HIV primary care clinic on their knowledge and comfort developing management plans for CNCP. IRB waiver was obtained.
Results. A total of 249 HIV infected patients were seen from January 2017 to May 2017. Forty-one of 249 (16%) of patients were identified as a having CNCP and of these patients, all were treated with opioids. MSK symptoms encompassed 28/41 (68%) of the total complaints. This included back pain (n = 20), lower extremity pain (n = 10), and upper extremity pain (n = 2). Only 5/41 (17%) patients were prescribed physical therapy for their pain complaints. Fifteen of 20 (75%) of IM residents responded to a survey on their comfort and knowledge in treating CNCP. None of the 15 (0%) felt completely comfortable developing a plan for CNCP, 2/15 (13%) felt their examination skills were adequate in assessing MSK symptoms in patients with CNCp. 12/15 (80%) felt working in collaboration with a physical therapist (PT) would be beneficial in developing effective treatment plans and 10/15 (67%) thought working in collaboration with a PT would help further develop their examination skills.
Conclusion. A survey of our IM residents has found gaps in both knowledge and comfort in CNCP pain management and high levels of opioid prescriptions in our HIV primary care clinic. Here we provide evidence that IM residents require additional training in treating CNCP in HIV patients and are interested in multidisciplinary approaches to development of non-pharmacologic treatment plans for HIV infected patients with CNCP.
Disclosures. 
